Molnupiravir Administered at Human Effect Size-Equivalent Dose

molnupiravir dose  Molnupiravir should be started as soon as possible after a diagnosis of symptomatic COVID-19 has been made and within five days of symptom onset Missed doses – Do not take two doses together to make up for a missed dose Getting the most from your treatment Treatment with molnupiravir should be started

Two oral drugs, molnupiravir and paxlovid , provide equivalent therapeutic benefit in preventing severe COVID-19 in Why am I taking LAGEVRIO? LAGEVRIO contains the active ingredient molnupiravir You are being given LAGEVRIO for the treatment of coronavirus disease

Breastfeeding is not recommended during treatment and for 4 days after the last dose of molnupiravir A lactating individual may consider interrupting consistent and reliable method of contraception for 3 months after the male has completed the last dose of this medication 2) Men of reproductive age • If